Watched a few videos could get access to. An interesting one when RMcW was 7 weeks into job.
What her key deliverables were around CLTX and how this is not commercially viable in present format due to method of delivery and minimal expertise to do so. Rather than 1 in Oz, need 1 in each hospital. Stuff that Big Stein has mentioned . Thx.
interviewer was really excited about the NK trial for a number of reasons. Called it the potential company maker.
Lost a dear lady to brain tumour not so long ago. Got some profits from a crazy MSB ride that sunk in recently.
Notice plenty of posters been in since inception, around 260m market cap when reading and going back through the posts? 4 year old company or thereabouts now.
MSB survived as it has always been able to raise cash. Particularly with SurgCentre and GG lately. AW and RP in the meantime, the visy board guy on Team Trump. Maybe ex Carlton board member while back.
This seems to be different play. To raise interest, develop the asserts and be ripe for a takeover from bigger fish
I see CEO been involved with a few others, Telestra and Wesfarmers with the now Warnie Foundation although in biotech space. One CoY split from 0 to 280m valuation or so......in the video. Maybe August last year.
She has a lot to smile about. PhD, dream space to work, CEO on resume now which always the plan, back in Melbourne her home town around Monash alumni and a suite of goals, of performance indicators to meet. She may see this as her potential legacy, to grow novel treatment, paradigm shifts in how things done and not just save lives but impact the quality of life we still have.
Keen to see where this lands, if anywhere. Definitely not a biotech investor. Just chucking in some funds for old girl, hoping she looking down favourably.
Thanks for the read of those whom contributing over years and are biotech investors. Mine is just musings out loud......
MJ
Add to My Watchlist
What is My Watchlist?
